Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Volker Insider Profile
4 Followers
Christopher Volker, COO at NeuroOne Medical Technologies, holds 75.00K shares in NeuroOne Medical Technologies (Ticker: NMTC). Most recently, Christopher Volker Bought $75,000 shares of NeuroOne Medical Technologies on Dec 26, 2023 for an estimated value of 105.00K.
Christopher Volker has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher Volker's holdings
Insider Roles
COO
Roles that Christopher Volker holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Christopher Volker
Christopher Volker's Trading History
List of latest transactions for each holding click on a transaction to see Christopher Volker's performance on stock
You May Also Like
Christopher Volker insider profile FAQ
What is the percentage of profitable transactions made by Christopher Volker?
The percentage of profitable transactions made by Christopher Volker is ―.
What is the average return per transaction made by Christopher Volker?
The average return per transaction made by Christopher Volker is ―.
What stocks does Christopher Volker hold?
Christopher Volker holds: NMTC stocks.
What was Christopher Volker’s latest transaction?
Christopher Volker latest transaction was an Informative Buy of $105.00K.
What was Christopher Volker's most profitable transaction?
Christopher Volker’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christopher Volker's role in NeuroOne Medical Technologies?
Christopher Volker's role in NeuroOne Medical Technologies is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.